Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

29.01.2024

1 Am J Surg Pathol
1 BMC Cancer
3 Br J Cancer
1 Curr Treat Options Oncol
8 Gynecol Oncol
1 Nat Med
1 Semin Oncol



    Am J Surg Pathol

  1. YANG B, Chour W, Salazar CG, Zamiara P, et al
    Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Am J Surg Pathol. 2023 Nov 10. doi: 10.1097/PAS.0000000000002149.
    >> Share


    BMC Cancer

  2. SONG G, Sun Z, Chu M, Zhang Z, et al
    FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.
    BMC Cancer. 2024;24:122.
    >> Share


    Br J Cancer

  3. NICUM S, McGregor N, Austin R, Collins L, et al
    Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
    Br J Cancer. 2024 Jan 20. doi: 10.1038/s41416-023-02567.
    >> Share

  4. LANDOLFO C, Ceusters J, Valentin L, Froyman W, et al
    Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02578.
    >> Share

  5. HERRINGTON CS, Oswald AJ, Stillie LJ, Croy I, et al
    Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02508.
    >> Share


    Curr Treat Options Oncol

  6. WANG JY, Gross M, Urban RR, Jorge S, et al
    Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer.
    Curr Treat Options Oncol. 2024 Jan 4. doi: 10.1007/s11864-023-01171.
    >> Share


    Gynecol Oncol

  7. BAN D, Housley SN, Matyunina LV, McDonald LD, et al
    A personalized probabilistic approach to ovarian cancer diagnostics.
    Gynecol Oncol. 2024;182:168-175.
    >> Share

  8. YANG Q, Peng X, Nian Z, Yuan S, et al
    UCHL-3 as a potential biomarker of ovarian cancer.
    Gynecol Oncol. 2024;182:156-167.
    >> Share

  9. WEIGERT M, Cui XL, West-Szymanski D, Yu X, et al
    5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
    Gynecol Oncol. 2024;182:82-90.
    >> Share

  10. TORTORELLA L, Cappuccio S, Giannarelli D, Nero C, et al
    Distribution and prognostic role of BRCA status in elderly ovarian cancer patients.
    Gynecol Oncol. 2024;182:57-62.
    >> Share

  11. LEVINE MD, Wang H, Sriram B, Khan A, et al
    Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
    Gynecol Oncol. 2024;182:51-56.
    >> Share

  12. KAHN RM, Ma X, Gordhandas S, Yeoshoua E, et al
    Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
    Gynecol Oncol. 2024;182:141-147.
    >> Share

  13. KIM SI, Joung JG, Kim YN, Park J, et al
    Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
    Gynecol Oncol. 2024;182:7-14.
    >> Share

  14. HANNIBAL CG, Kjaer SK, Galanakis M, Hertzum-Larsen R, et al
    History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
    Gynecol Oncol. 2024;182:1-6.
    >> Share


    Nat Med

  15. AMGAD M, Hodge JM, Elsebaie MAT, Bodelon C, et al
    A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer.
    Nat Med. 2024;30:85-97.
    >> Share


    Semin Oncol

  16. GOLDLUST IS, Guidice E, Lee JM
    PARP inhibitors in ovarian cancer.
    Semin Oncol. 2024 Jan 14:S0093-7754(24)00001.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016